982. Effect of Hepatic Impairment on the Safety and Pharmacokinetics of Rezafungin

BACKGROUND: Rezafungin (RZF) is a novel echinocandin antifungal being developed for treatment of candidemia and invasive candidiasis, and for prevention of invasive fungal diseases among immunosuppressed patients. In the Phase 2 and Phase 3 treatment trials of rezafungin compared with caspofungin (S...

Descripción completa

Detalles Bibliográficos
Autores principales: Huguet, Jade, Ong, Voon, Sandison, Taylor, Melara, Rebeca M, Marbury, Thomas C, Jandourek, Alena, Flanagan, Shawn
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Poster Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8643917/
http://dx.doi.org/10.1093/ofid/ofab466.1176

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8643917/
http://dx.doi.org/10.1093/ofid/ofab466.1176

Ejemplares similares